The adjuvanted RSV vaccine RSVPreF3 elicits modest immune responses in lung transplant and allogeneic hematopoietic cell transplant recipients at the highest risk for infection.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/how-well-does-rsv-vaccine-work-transplant-recipients-2025a1000r4k?src=rss
Author :
Publish date : 2025-10-08 12:49:00
Copyright for syndicated content belongs to the linked Source.
